Veterinary Vaccines Market Rise to a Valuation of US$ 11.40 Billion by 2024
Targeted in-licensing and acquisitions, expansion of global manufacturing and supply capacities, and increased investments towards research and development activities are some of the key strategies adopted by leading vendors in the market. A recent instance is the strategic alliance of Sanofi with Boehringer Ingelheim in June 2016. Under this alliance, an exchange of Boehringer Ingelheim’s consumer healthcare (CHC) unit with Sanofi’s animal health business took place.
Read Report Overview @ https://www.transparencymarketresearch.com/veterinary-vaccines-market.html
In the past few years, factors such as globalization and intense changes in global climate have led to a vast rise in the prevalence of zoonotic diseases globally. To prevent the huge loss of livestock and potential threat to human lives that global outbreaks of several zoonotic diseases cause, there has been a surge in government initiatives aimed at mandating vaccination for companion and farm animals. Active efforts are also undertaken by government and non-government bodies to increase awareness among pet and livestock owners about rampant and hazardous animal diseases, their symptoms, and medication.
Also, the vast surge in the global demand for meat, chicken, eggs, and milk is compelling livestock farmers to pay proper attention to vaccination to ensure the production excellent quality products and thereby keep their businesses sustainable and profitable. In the past few years, pet ownership and the money spent for ensuring health and wellness of companion animals has significantly increased on a global front. According to the national pet owners’ survey of 2015-2016, 65% households in the U.S. own a pet. The pet industry in the U.S. had a valuation of US$ 60.59 bn in 2015 and is expected to rise to US$62.75 bn in 2016.
These factors are collectively expected to have a significant impact on the overall development of the global veterinary vaccines market in the next few years. Moreover, the market is also expected to benefit enormously from the vast rise in research and development activities and increased demand for advanced and more effective veterinary vaccines across the globe.
National governments play a key role in deciding the profitability of the veterinary vaccines market. For instance, the Government of India purchases foot-and-mouth disease (FMD) vaccines in bulk from manufacturers and supplies it to different parts of the country. Such bilk purchases result in reduced prices of the vaccines, substantially bringing down the profitability of manufacturers.
The short product exclusivity period in the animal healthcare industry, of nearly 3-5 years results in intense competition from cheaper generic substitutes and over-the-counter products. Additionally, strict regulations for product approval and the resulting decline in the number of products that can enter the market limit the overall profitability of the global veterinary vaccines market substantially.
Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=215
The global market for veterinary vaccines is expected to expand at a healthy 6.9% CAGR over the period between 2016 and 2024. The market, which had a valuation of US$6,271.8 mn in 2015, is expected to rise to US$11,403.6 mn by 2024. In terms of technology type, the segment of live attenuated vaccines is presently the leading contributor to market’s overall revenues. The segment accounted for over 44% in the global market in 2015. Geography-wise, North America held nearly 37% of the global market’s overall revenues in 2015.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Veterinary Vaccines Market Rise to a Valuation of US$ 11.40 Billion by 2024 here
News-ID: 830072 • Views: 197
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment
More Releases for Sanofi
Isoproterenol Market Forecast & Opportunities 2019| SANOFI AVENTIS US, HOSPIRA, …
The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Isoproterenol market. It includes Porter’s Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Isoproterenol Market. We have provided deep analysis of the vendor landscape to give you a complete picture
Global Orphan Drugs Market 2018 - Celgene, Roche, Pfizer, Sanofi
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease. Get Free Sample Copy of Report Here: http://bit.ly/2TVTFWT Scope of the Report: This report focuses on the Orphan Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type
MRSA Antibiotics Market Is Thriving Worldwide with Pfizer, Sanofi & Novartis
HTF MI released a new market study on Global and Asia MRSA Antibiotics Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study
Biotechnology Market Is Booming | Roche, Pfizer, Merck, Sanofi, AstraZeneca
HTF MI recently introduced Global Biotechnology Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Johnson & Johnson, Roche, Pfizer, Merck, Sanofi, AstraZeneca, Gilead, CELGENE CORPORATION, Biogen,
Global Vasodilator Market 2017 : GSK, Merck, Sanofi
Vasodilator Market 2017 A market study based on the " Vasodilator Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Vasodilator Market 2017’. The research report analyses the historical as well as present performance of the worldwide Vasodilator industry, and makes predictions on the future status of Vasodilator market on the basis of this analysis. Get Free Sample Copy of Report Here : http://www.marketsnresearch.com/request-for-sample.html?repid=17548 Top Manufacturers
Global Consumer Healthcare Products Market Research Report 2017 - Sanofi, GSK, M …
n this report, the global Consumer Healthcare Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Consumer Healthcare Products in these regions, from 2012 to 2022